Package 68788-8769-6

{"route": ["ORAL"], "spl_id": "17da2d67-85ad-4170-bd4e-1b9ca4565950", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["093c4a61-02d9-4b55-b612-569aa25d3f2a"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8769-1)", "package_ndc": "68788-8769-1", "marketing_start_date": "20241119"}, {"sample": false, "description": "20 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8769-2)", "package_ndc": "68788-8769-2", "marketing_start_date": "20241119"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8769-3)", "package_ndc": "68788-8769-3", "marketing_start_date": "20241119"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8769-6)", "package_ndc": "68788-8769-6", "marketing_start_date": "20241119"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8769-8)", "package_ndc": "68788-8769-8", "marketing_start_date": "20241119"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8769-9)", "package_ndc": "68788-8769-9", "marketing_start_date": "20241119"}], "brand_name": "Bupropion hydrochloride", "product_id": "68788-8769_17da2d67-85ad-4170-bd4e-1b9ca4565950", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68788-8769", "generic_name": "Bupropion hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA216800", "marketing_category": "ANDA", "marketing_start_date": "20241119", "listing_expiration_date": "20271231"}